Related Experiment Video
Updated: May 11, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes update: screening and diagnosis
Deborah R Erlich1, David C Slawson, Allen Shaughnessy
1Tufts University, Boston, MA 02111, USA. deborah.erlich@tufts.edu
FP Essentials
|May 22, 2013
Summary
Primary care physicians should screen hypertensive patients for type 2 diabetes. Early screening and management using patient-centered evidence can improve outcomes and reduce cardiovascular mortality in diabetic patients.
Area of Science:
- Endocrinology
- Cardiology
- Primary Care Medicine
Background:
- Patients with type 2 diabetes and hypertension face elevated cardiovascular mortality risk.
- Proactive screening and management are crucial for improving patient longevity and quality of life.
Purpose of the Study:
- To guide primary care physicians in evidence-based screening and management of type 2 diabetes.
- To emphasize the importance of screening asymptomatic hypertensive patients for diabetes.
Main Methods:
- Screening via fasting plasma glucose, A1c, or oral glucose tolerance tests.
- Diabetes diagnosis based on abnormal glucose or A1c levels.
- Comprehensive assessment including blood pressure, BMI, lipids, kidney function, and vaccination/smoking status post-diagnosis.
Main Results:
- Metformin use can delay diabetes onset in high-risk individuals.
- Lifestyle modifications (weight reduction, physical activity, diet) are key for prevention and management.
- Pharmacological interventions (statins, antihypertensives) are indicated for managing cardiovascular risk factors.
Conclusions:
- Screening asymptomatic hypertensive patients for type 2 diabetes is recommended.
- A patient-centered approach focusing on morbidity and mortality is essential for diabetes care.
- Integrated management of diabetes, hypertension, and cardiovascular risk factors improves patient outcomes.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...